The Laura W. Bush Institute for Women's Health partners with the Cancer Center in delivery of cancer prevention services to the South Plains region and in cancer biobanking.
The NCI Pediatric Preclinical Testing Program (PPTP), a consortium of laboratories that carry out preclinical testing of new drugs in laboratory models of childhood cancer.
CTNeT's vision is to create a network for cancer clinical trials across the state which leverages the combined intellectual strength of academic and community institutions in Texas to provide access to cancer-related clinical trials for all Texans. Such a network will improve patient care while providing a conduit for testing novel drugs, diagnostics, and devices.
The TXCCR is a consortium of translational laboratory investigators that collaborate to establish, bank, and distribute cancers grown in the laboratory and in special mice that will serve as models to study the biology of cancer and to develop novel approaches to therapy.
The TTUHSC Cancer Center is one of 3 sites for the Texas Cancer Research Biobank (TCRB; www.TXCRB.org). The TCRB carries out biobanking for cancer in multiple institutions across Texas and will conduct state-of-the-art genomic profiling of many of the banked cancers. The TCRB works closely with the Texas Cancer Cell Repository (www.TXCCR.org) and the Clinical Trials Network of Texas (www.CTNeT.org).
The Children's Oncology Group (COG) is the national organization of > 200 institutions that carries our research in childhood cancer.
The New Approaches to Neuroblastoma Therapy (NANT) consortium is a clinical consortium of ~ 14 academic institutions that conduct early phase clinical trials testing new therapies for recurrent neuroblastoma, a childhood cancer.
The South Plains Oncology Consortium (SPOC) is a consortium funded by the State of Texas to carry out research on new anti-cancer drugs. Members of SPOC include TTUHSC School of Medicine, Covenant Medical Center (Lubbock), MD Anderson Cancer Institute (Houston), University of Oklahoma (Oklahoma City), and UT Southwestern Medical Center (Dallas). SPOC also conducts trials in collaboration with the California Cancer Consortium and the National Cancer Institute.